Bodil Als-Nielsen

Summary

Affiliation: Copenhagen Trial Unit
Country: Denmark

Publications

  1. pmc Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ
    Lise L Kjaergard
    Cochrane Hepatobiliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital, Department 7102, H S Rigshospitalet, DK 2100 Copenhagen, Denmark
    BMJ 325:249. 2002
  2. pmc Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials
    Bodil Als-Nielsen
    Cochrane Hepato Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital, Department 7102, H S Rigshospitalet, DK 2100 Copenhagen, Denmark
    BMJ 328:1046. 2004
  3. ncbi request reprint [Nonabsorbable disaccharides for the treatment of hepatic encephalopathy--a systemic review of randomized clinical trials--a secondary publication]
    Bodil E Als-Nielsen
    H S Rigshospitalet, Copenhagen Trial Unit, Center for Klinisk Interventionsforskning
    Ugeskr Laeger 167:179-82. 2005
  4. ncbi request reprint Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?
    Bodil Als-Nielsen
    The Copenhagen Trial Unit, Center for Clinical Intervention Research, Copenhagen University Hospital, Copenhagen, Denmark
    JAMA 290:921-8. 2003
  5. ncbi request reprint [Are treatment effects or adverse effects of significance for the association between financing and conclusions in randomized trials?]
    Bodil E Als-Nielsen
    H S Rigshospitalet, Center for Klinisk Interventionsforskning, Copenhagen Trial Unit
    Ugeskr Laeger 166:1676-8. 2004
  6. doi request reprint Chlamydia pneumoniae IgG and IgA antibody titers and prognosis in patients with coronary heart disease: results from the CLARICOR trial
    Jørgen Hilden
    The Copenhagen Trial Unit, Center for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, DK 2100 Copenhagen, Denmark
    Diagn Microbiol Infect Dis 66:385-92. 2010
  7. doi request reprint Statin treatment prevents increased cardiovascular and all-cause mortality associated with clarithromycin in patients with stable coronary heart disease
    Gorm B Jensen
    Department of Cardiology, Hvidovre Hospital, Copenhagen University Hospital, Denmark
    J Cardiovasc Pharmacol 55:123-8. 2010
  8. pmc Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial
    Christian M Jespersen
    Bispebjerg Hospital, Copenhagen University Hospital, Department of Cardiology Y, Bispebjerg Bakke 23, DK 2400 Copenhagen, Denmark
    BMJ 332:22-7. 2006
  9. ncbi request reprint Artificial and bioartificial support systems for liver failure: a Cochrane Hepato-Biliary Group Protocol
    Jianping Liu
    The Cochrane Hepato Biliary Group, The Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital, H S Rigshospitalet, Blegdamsvej 9, DK 2100, Copenhagen, Denmark
    Liver 22:433-8. 2002
  10. ncbi request reprint Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review
    Lise L Kjaergard
    The Cochrane Hepato Biliary Group, The Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital, H S Rigshospitalet, Blegdamsvej 9, DK 2100, Copenhagen, Denmark
    JAMA 289:217-22. 2003

Detail Information

Publications14

  1. pmc Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ
    Lise L Kjaergard
    Cochrane Hepatobiliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital, Department 7102, H S Rigshospitalet, DK 2100 Copenhagen, Denmark
    BMJ 325:249. 2002
    ..To assess the association between competing interests and authors' conclusions in randomised clinical trials...
  2. pmc Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials
    Bodil Als-Nielsen
    Cochrane Hepato Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital, Department 7102, H S Rigshospitalet, DK 2100 Copenhagen, Denmark
    BMJ 328:1046. 2004
    ..To assess the effects of non-absorbable disaccharides (lactulose and lactitol) in patients with hepatic encephalopathy...
  3. ncbi request reprint [Nonabsorbable disaccharides for the treatment of hepatic encephalopathy--a systemic review of randomized clinical trials--a secondary publication]
    Bodil E Als-Nielsen
    H S Rigshospitalet, Copenhagen Trial Unit, Center for Klinisk Interventionsforskning
    Ugeskr Laeger 167:179-82. 2005
  4. ncbi request reprint Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?
    Bodil Als-Nielsen
    The Copenhagen Trial Unit, Center for Clinical Intervention Research, Copenhagen University Hospital, Copenhagen, Denmark
    JAMA 290:921-8. 2003
    ..Previous studies indicate that industry-sponsored trials tend to draw proindustry conclusions...
  5. ncbi request reprint [Are treatment effects or adverse effects of significance for the association between financing and conclusions in randomized trials?]
    Bodil E Als-Nielsen
    H S Rigshospitalet, Center for Klinisk Interventionsforskning, Copenhagen Trial Unit
    Ugeskr Laeger 166:1676-8. 2004
  6. doi request reprint Chlamydia pneumoniae IgG and IgA antibody titers and prognosis in patients with coronary heart disease: results from the CLARICOR trial
    Jørgen Hilden
    The Copenhagen Trial Unit, Center for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, DK 2100 Copenhagen, Denmark
    Diagn Microbiol Infect Dis 66:385-92. 2010
    ..Smoking-related lung disease probably underlies the link between heart disease and increased IgG titers...
  7. doi request reprint Statin treatment prevents increased cardiovascular and all-cause mortality associated with clarithromycin in patients with stable coronary heart disease
    Gorm B Jensen
    Department of Cardiology, Hvidovre Hospital, Copenhagen University Hospital, Denmark
    J Cardiovasc Pharmacol 55:123-8. 2010
    ..41). Multivariate analysis and 6-year follow up confirmed these results. Concomitant statin treatment in stable patients with coronary heart disease abrogated the observed increased CV mortality associated with 2 weeks of clarithromycin...
  8. pmc Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial
    Christian M Jespersen
    Bispebjerg Hospital, Copenhagen University Hospital, Department of Cardiology Y, Bispebjerg Bakke 23, DK 2400 Copenhagen, Denmark
    BMJ 332:22-7. 2006
    ..To determine if the macrolide clarithromycin affects mortality and cardiovascular morbidity in patients with stable coronary heart disease...
  9. ncbi request reprint Artificial and bioartificial support systems for liver failure: a Cochrane Hepato-Biliary Group Protocol
    Jianping Liu
    The Cochrane Hepato Biliary Group, The Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital, H S Rigshospitalet, Blegdamsvej 9, DK 2100, Copenhagen, Denmark
    Liver 22:433-8. 2002
    ..This review is to evaluate the beneficial and harmful effects of artificial and bioartificial support systems for acute and acute-on-chronic liver failure...
  10. ncbi request reprint Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review
    Lise L Kjaergard
    The Cochrane Hepato Biliary Group, The Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital, H S Rigshospitalet, Blegdamsvej 9, DK 2100, Copenhagen, Denmark
    JAMA 289:217-22. 2003
    ..Artificial and bioartificial support systems may provide a "bridge" for patients with severe liver disease to recovery or transplantation...
  11. pmc Clarithromycin for 2 weeks for stable coronary heart disease: 6-year follow-up of the CLARICOR randomized trial and updated meta-analysis of antibiotics for coronary heart disease
    Christian Gluud
    The Copenhagen Trial Unit, Center for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Cardiology 111:280-7. 2008
    ..Here we report the 6-year mortality of clarithromycin- versus placebo-exposed patients and updated meta-analyses...
  12. doi request reprint Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?
    Kristian Thorlund
    Copenhagen Trial Unit, Center for Clinical Intervention Research, Copenhagen University Hospital, Department 3344, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
    Int J Epidemiol 38:276-86. 2009
    ..e. applying trial sequential monitoring boundaries)...
  13. doi request reprint Hepato-biliary clinical trials and their inclusion in the Cochrane Hepato-Biliary Group register and reviews
    Sarah Louise Klingenberg
    The Cochrane Hepato Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    J Gastroenterol Hepatol 26:649-56. 2011
    ..In this overview, we present the growth of The CHBG Controlled Trials Register, as well as the systematic reviews that have been produced since March 1996...
  14. ncbi request reprint [Independent research should be supported]
    Bodil Als-Nielsen
    Ugeskr Laeger 165:4237; author reply 4237-8. 2003